Mogamulizumab is a humanized monoclonal antibody designed for the treatment of cancers.
Mogamulizumab was developed by Kyowa Hakko Kirin Co., Ltd.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
